MetLife Investment Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$419K	Buy	23,326 +881	+4%	+$17.7K	﹤0.01%	1835
2025 Q4	$526K	Sell	22,445 -321	-1%	-$6.96K	﹤0.01%	1776
2025 Q3	$454K	Hold	22,766	–	–	﹤0.01%	1853
2025 Q2	$312K	Hold	22,766	–	–	﹤0.01%	1936
2025 Q1	$252K	Hold	22,766	–	–	﹤0.01%	2077
2024 Q4	$242K	Buy	22,766 +2,727	+14%	+$32.6K	﹤0.01%	2201
2024 Q3	$254K	Hold	20,039	–	–	﹤0.01%	2161
2024 Q2	$336K	Buy	20,039 +5,413	+37%	+$77K	﹤0.01%	1940
2024 Q1	$219K	Hold	14,626	–	–	﹤0.01%	2150
2023 Q4	$219K	Buy	14,626 +4,223	+41%	+$54.8K	﹤0.01%	2195
2023 Q3	$146K	Hold	10,403	–	–	﹤0.01%	2376
2023 Q2	$108K	Buy	+10,403	New	+$115K	﹤0.01%	2631
2021 Q4	–	Sell	-7,354	Closed	-$124K	–	2553
2021 Q3	$124K	Buy	+7,354	New	+$117K	﹤0.01%	2346
2021 Q2	–	Sell	-8,654	Closed	-$169K	–	2489
2021 Q1	$169K	Sell	8,654 -1,336	-13%	-$28.4K	﹤0.01%	2141
2020 Q4	$180K	Hold	9,990	–	–	﹤0.01%	2032
2020 Q3	$193K	Hold	9,990	–	–	﹤0.01%	1886
2020 Q2	$261K	Hold	9,990	–	–	﹤0.01%	1745
2020 Q1	$178K	Hold	9,990	–	–	﹤0.01%	1768
2019 Q4	$333K	Hold	9,990	–	–	﹤0.01%	1680
2019 Q3	$238K	Buy	+9,990	New	+$327K	﹤0.01%	1845